Chimeric Antigen Receptor | CHOP Research Institute
 

Chimeric Antigen Receptor

Cornerstone Blog

Cell and Gene Therapy Collaborative Celebrates 5 Years of Ingenuity, Innovation

Published on
Jul 29, 2024
Cell and Gene Therapy Collaborative Celebrates 5 Years
The CGTC helps to accelerate clinical trials, training, and research, enabling CHOP to remain a global leader in the space.
Cornerstone Blog

Targeting Diffuse Midline Glioma: Q&A With Cassie Kline, MD, MAS, and Jessica Foster, MD

Published on
Feb 22, 2023
Seed Grant Funds Research to Target Diffuse Midline Glioma
Cassie Kline, MD, MAS, and Jessica Foster, MD, received a seed grant to study CAR T-cell and radiotherapy for diffuse midline gliomas.
Cornerstone Blog

CAR T-cell Therapy for Pediatric Brain Tumors: Q&A With Jessica Foster, MD

Published on
May 23, 2022
CAR T-cell Therapy for Brain Tumors
Neuro-oncologist Jessica Foster MD, is investigating chimeric antigen receptor (CAR) T-cell therapy for brain tumors.
Sarah A. Richman, MD, PhD
Sarah A. Richman Headshot

Dr. Richman's research focuses on chimeric antigen receptor (CAR) T cells targeting solid tumors with the goal of translating these findings to this unmet clinical need.

E-mail:
richmans [at] chop.edu